Surgical Science Sweden AB (publ)
SUSRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $884 | $883 | $803 | $367 |
| % Growth | 0.1% | 10% | 118.8% | – |
| Cost of Goods Sold | $286 | $270 | $271 | $101 |
| Gross Profit | $598 | $613 | $532 | $266 |
| % Margin | 67.6% | 69.4% | 66.2% | 72.5% |
| R&D Expenses | $196 | $182 | $173 | $66 |
| G&A Expenses | $77 | $73 | $64 | $66 |
| SG&A Expenses | $252 | $240 | $202 | $146 |
| Sales & Mktg Exp. | $175 | $168 | $138 | $80 |
| Other Operating Expenses | $5 | $2 | -$6 | -$2 |
| Operating Expenses | $454 | $424 | $369 | $209 |
| Operating Income | $144 | $189 | $163 | $89 |
| % Margin | 16.3% | 21.4% | 20.3% | 24.2% |
| Other Income/Exp. Net | $14 | $79 | $46 | -$23 |
| Pre-Tax Income | $158 | $268 | $208 | $66 |
| Tax Expense | $26 | $34 | $20 | -$20 |
| Net Income | $132 | $234 | $188 | $86 |
| % Margin | 14.9% | 26.5% | 23.4% | 23.5% |
| EPS | 2.58 | 4.59 | 3.7 | 2.03 |
| % Growth | -43.8% | 24.1% | 82.3% | – |
| EPS Diluted | 2.58 | 4.59 | 3.69 | 2.02 |
| Weighted Avg Shares Out | 51 | 51 | 51 | 42 |
| Weighted Avg Shares Out Dil | 51 | 51 | 51 | 43 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14 | $79 | $65 | $32 |
| Interest Expense | $0 | $15 | $1 | $23 |
| Depreciation & Amortization | $25 | $23 | $44 | $26 |
| EBITDA | $170 | $214 | $271 | $115 |
| % Margin | 19.2% | 24.3% | 33.8% | 31.4% |